Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy

European Heart Journal

Volumn 27, Issue 15, 2006, Pages 1805-1810

  Jassal, Davinder S ^a   Neilan, Tomas G ^a   Fifer, Michael A ^a   Palacios, Igor F ^a   Lowry, Patrica A ^a   Vlahakes, Gus J ^a   Picard, Michael H ^a   Yoerger, Danita M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alcohol septal ablation; Diastolic dysfunction; Echocardiography; Hypertrophic obstructive cardiomyopathy

Indexed keywords

ADULT; AGED; ALCOHOL SEPTAL ABLATION; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT ATRIUM; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE SEPTUM; HEART VOLUME; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; ISOVOLUMETRIC RELAXATION TIME; MALE; MITRAL VALVE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; THICKNESS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; ETHANOL; FEMALE; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; SCLEROSING SOLUTIONS; SOLVENTS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33748054256     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl106     Document Type: Article

References (32)

1. Nishimura RA, Holmes DR. Hypertrophic obstructive cardiomyopathy. N Engl J Med 2004;350:1320-1327.
2. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-1320.
3. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Task Force on Clinical Expert Consensus documents. American College of Cardiology: Committee for Practice Guidelines. European Society of Cardiology. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-1713.
4. Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, Martin M, Tuzcu EM, Smedira NG, Lytle B, Thomas JD. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001;38:1994-2000.
5. Maron BJ. Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet 2000;355:425-426.
6. Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He ZX, Verani MS, Roberts R, Spencer WH III. Echocardiography-guided ethanol septal reduction for hypertrophic cardiomyopathy. Circulation 1998;98:1750-1755.
7. Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy. NYHA functional class III or IV and outflow obstruction only under provocable conditions. Circulation 2002;106:454-459.
8. Schulz-Menger J, Strohm O, Waigand J, Waigand J, Uhlich F, Dietz R, Friedrich, MG. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation 2000;101:1764-1766.
9. Gietzen FH, Leuner CJ, Raute-Kreinsen U, Dellmann A, Hegselmann J, Strunk-Mueller C, Kuhn HJ. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 1999;20:1342-1354.
10. Faber L, Meissner A, Ziemssen P, Seggewiss H. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first 25 series. Heart 2000;83:326-331.
11. Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H. Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients. Heart 2004;90:638-644.
12. Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Zoghbi WA, Quinones MA, Spencer WH III. Changes in left ventricular killing and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic cardiomyopathy. J Am Coll Cardiol 1999;34:1123-1128.
13. Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Zoghbi WA, Quinones MA, Spencer WH III. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 1999;99:344-347.
14. Chen AA, Palacios IF, Mela T, Yoerger DM, Picard MH, Vlahakes GJ, Lowry PA, Fifer MA. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol 2006;97:264-269.
15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
16. Zogbhi WA, Enriquez-Sorano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, American Society of Echocardiography. Recommendations for evaluation for the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
17. Nishihara K, Mikami T, Takatsuji H, Onozuka H, Saito N, Yamada S, Ursawa K, Kitabatake A. Usefulness of early diastolic flow propagation velocity measured by color M-mode Doppler technique for the assessment of left ventricular diastolic function in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2000;13:801-808.
18. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998;32:865-875.
19. Garcia MJ, Ares MA, Asher C, Rodríguez L, Vandervoort P, Thomas JD. An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. J Am Coll Cardiol 1997;29:448-454.
20. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-1533.
21. Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes DR Jr. Tajik AJ. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 1996;28:1226-1233.
22. Rakoswki H, Sasson Z, Wiggle ED. Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy. J Am Soc Echocardiogr 1988;1:31-47.
23. Maron BJ, Spirito P, Green KJ, Wesley YE, Bowon RO, Arce J. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987;10:733-742.
24. Mazur W, Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Roberts R, Spencer WH III. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic cardiomyopathy. Circulation 2001;103:1492-1496.
25. Nihoyannopoulos P, Karatasakis G, Frenneaux M, McKenna WJ, Oakley CM. Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol 1992;19:536-540.
26. Matsumura Y, Elliott PM, Virdee MS, Sorajja P, Doi Y, McKenna WJ. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart 2002;87:247-251.
27. Ishida Y, Meisner JS, TSujioka K, Gallo JI, Yoran C, Frater RW, Yellin EL. Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 1986;74:187-196.
28. Nagueh SF, Bachinski LL, Meyer D, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-130.
29. Nagueh SF, Lakkis NM, Middleton KJ, Middleton KJ, Spencer WH III, Zoghbi WA, Quinones MA. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999;254-261.
30. Woo A, Williams WG, Choi R, Wigle ED, Rozenblyum E, Fedwick K, Siu S, Ralph-Edwards A, Rakowski H. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005;111:2033-2041.
31. Lakkis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH III. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: 1 year follow-up. J Am Coll Cardiol 2000;36:852-855.
32. Van Dockum WG, Beck AM, ten Cate FJ, ten Berg JM, Bondarenko O, Gotte MJ, Twisk JW, Hofman MB, Visser CA, van Rossum AC. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic cardiomyopathy. Circulation 2005;111:2503-2508.